CN100471519C - Medicine composition for treating stomach diseases and preparation method and application thereof - Google Patents
Medicine composition for treating stomach diseases and preparation method and application thereof Download PDFInfo
- Publication number
- CN100471519C CN100471519C CNB2006100213944A CN200610021394A CN100471519C CN 100471519 C CN100471519 C CN 100471519C CN B2006100213944 A CNB2006100213944 A CN B2006100213944A CN 200610021394 A CN200610021394 A CN 200610021394A CN 100471519 C CN100471519 C CN 100471519C
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- powder
- bletillae
- gastropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 208000018556 stomach disease Diseases 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 229940079593 drug Drugs 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims description 11
- 208000012895 Gastric disease Diseases 0.000 claims abstract description 29
- 241000218176 Corydalis Species 0.000 claims abstract description 23
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 51
- 239000002994 raw material Substances 0.000 claims description 30
- 210000000582 semen Anatomy 0.000 claims description 30
- 240000002943 Elettaria cardamomum Species 0.000 claims description 23
- 235000005300 cardamomo Nutrition 0.000 claims description 23
- 208000002193 Pain Diseases 0.000 claims description 14
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 210000002784 stomach Anatomy 0.000 claims description 11
- 206010016766 flatulence Diseases 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 8
- 206010010774 Constipation Diseases 0.000 claims description 7
- 208000007882 Gastritis Diseases 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 208000032843 Hemorrhage Diseases 0.000 claims description 5
- 230000002496 gastric effect Effects 0.000 claims description 5
- 208000007107 Stomach Ulcer Diseases 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 208000000718 duodenal ulcer Diseases 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 201000005917 gastric ulcer Diseases 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 208000011580 syndromic disease Diseases 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 241001106067 Atropa Species 0.000 abstract description 13
- 239000000463 material Substances 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 244000199697 Amomum kepulaga Species 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000062241 Kaempferia galanga Species 0.000 abstract 1
- 235000013421 Kaempferia galanga Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 240000002505 Pogostemon cablin Species 0.000 abstract 1
- 235000011751 Pogostemon cablin Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000000513 Santalum album Species 0.000 abstract 1
- 235000008632 Santalum album Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 10
- 238000005303 weighing Methods 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 7
- 230000008673 vomiting Effects 0.000 description 7
- 230000004087 circulation Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 229940069428 antacid Drugs 0.000 description 4
- 239000003159 antacid agent Substances 0.000 description 4
- 230000001458 anti-acid effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000001156 gastric mucosa Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000001809 melena Anatomy 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 230000006578 abscission Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- -1 Bismuth aluminate compound Chemical class 0.000 description 2
- 208000001762 Gastric Dilatation Diseases 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- 201000000660 Pyloric Stenosis Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940104825 bismuth aluminate Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000041628 Aristolochia mollissima Species 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 241001289320 Asarum pulchellum Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000009737 qizhiweitong Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides a pharmaceutical composition for treating gastropathy, which is a medicament prepared by taking crude drugs or extracts of radix linderae, rhizoma bletillae, rhizoma corydalis, round cardamon seed, patchouli, immature bitter orange, magnolia officinalis, bletilla striata, cuttle bone, dandelion, rhubarb, cinnamon, galangal and sandalwood as active ingredients and adding belladonna and pharmaceutically acceptable auxiliary materials or auxiliary ingredients. The preparation method is simple, and the prepared medicament has the advantages of quick response, short treatment course, good curative effect and difficult recurrence, and provides a new choice for clinical treatment of gastropathy.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of gastropathy, specifically, it is to be the medicament that primary raw material is prepared from the Chinese crude drug, belongs to drug world.
Background technology
So-called gastropathy is actually the general designation of many diseases, and they have similar symptom, as upper abdomen gastral cavilty portion discomfort, pain, after meal glutted, heating installation, return acid, even feel sick, vomiting or the like.Common clinically gastropathy has the innocent and malignant tumour of acute gastritis, chronic gastritis, gastric ulcer, duodenal ulcer, gastroduodenal complex ulcer, stomach, the gastremia that also has prolapse of gastric mucosa, gastric mucosa abscission to cause is hemorrhage, acute gastric dilatation, pyloric obstruction etc., even diseases such as melena, constipation are also reduced gastropathy.
The main treatment means of gastropathy is based on " taking good care of ", " treatment " at present.
Western medicine gastropathy is based on " antacid, protection mucosa and anti-helicobacter pylori ", but side effect is obvious, but can only its side effect of gastric acid inhibitory can cause impotence and sexual disorder as first cyanogen rice croak; Bismuth aluminate compound (compound bismuth aluminate tablets) also is a kind of sour medicine that presses down, but the effect limitation can not suppress helicobacter pylori; Omeprazole can only press down acid, pain relieving still can not suppress helicobacter pylori, and price is higher.
The traditional Chinese medical science claims that gastropathy is that " gastric abscess " or " stomachache due to hyperactive liver-QI attacking the stomach " are commonly called as and are " peratodynia " or " motive pain ", the Chinese patent medicine of treatment gastropathy has XIANGSHA YANGWEI WAN, adds flavor Zuojin Wan, Aucklandiae and Amomi stomach-calming granule, WENWEISHU JIAONANG, yangweishu capsules, qizhi weitong granules (electuary), WEIDE peace sheet, Liuwei Anxiao are loose, WEISU CHONGJI etc., but these Chinese patent medicines can not be treated symptoms all in the gastropathy, and when the gastropathy acute attack effective disease controlling, be mainly used in daily conditioning and recover.
Still there is not at present a kind of medicine that can treat the various stomach symptom.
Summary of the invention
Technical problem to be solved by this invention provides a kind of pharmaceutical composition for the treatment of gastropathy.
The present composition is to contain the medicament that is prepared from following materials of weight proportions: 0.5~1 part of WUJINGEN, 5~10 parts of wooly datchmanspipe roots, 3~5 parts of Rhizoma Corydalis, 20~50 parts of Herba Taraxacis, 0.6~1 part of Cortex Cinnamomi.
Above-mentioned five tastes medicine anti inflammatory blood quickening, separate the spasm pain relieving, be monarch drug.Wherein, WUJINGEN is the root of aristolochiaceae plant black wool Herba Asari (beautiful Herba Asari) Asarum pulchellum Hemsl., has the effect of anti-inflammatory analgetic, and the effect of healing is arranged for gastric ulcer; Wooly datchmanspipe root is the root of aristolochiaceae plant Aristolochia mollissima Aristolochia mollissimaHance, has the cold syndrome of the stomach of dispelling, analgesic effect; The effect of Rhizoma Corydalis promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling; Herba Taraxaci heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, can hemostasis, pain relieving, preventing or arresting vomiting, elimination flatulence; Cortex Cinnamomi energy let the fire back to its origin, warming middle-JIAO to dispel cold can be treated the stomachache of Deficiency and coldness of spleen and stomach and be suffered from abdominal pain.
Further, it also contains the following weight proportion raw material: 0.6~0.8 part of roud cardamon seed, 2.5~10 parts of Herba Pogostemonis, 2.5~6 parts of Fructus Aurantii Immaturuss, 2.5~5 parts of Cortex Magnoliae Officinalis, 0.8~5 part in Lignum Santali Albi.
These five tastes that add have relieving distension by promoting circulation of QI, all stagnant effects of the gastrointestinal that disappears, and are ministerial drug.Wherein, roud cardamon seed removing dampness by means of aromatics, warming middle-JIAO to arrest vomiting, promoting qi circulation, resolving food retention; Herba Pogostemonis removing dampness by means of aromatics and middle preventing or arresting vomiting, the pathogenic factor in the exterior that looses, Herba Pogostemonis can not substitute with herba agastachis rugosae because of containing peculiar volatile ingredient in addition, influences the synergism between drug effect and the medicine; Fructus Aurantii Immaturus has dispelling the stagnated QI removing food stagnancy, therapeutic method to keep the adverse QI flowing downwards relieving constipation, effect that circulation of qi promoting power is strong; Cortex Magnoliae Officinalis circulation of qi promoting removing dampness intestinal stasis relieving, can treat diseases such as the spleen and stomach being stranded by dampness, abdominal distention, constipation; The Lignum Santali Albi promoting the circulation of QI to relieve pain.
Further, it also contains the following weight proportion raw material: 0.3~0.8 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.1~2 part of Os Sepiae, 0.2~1 part of Radix Et Rhizoma Rhei, 2.5~5 parts of Rhizoma Alpiniae Officinarums, Semen daturae Belladonna0.01~0.015 part.
The Pseudobulbus Bletillae (Rhizoma Bletillae) of adding on the basis of original ten herbal medicines, Os Sepiae, Semen daturae Belladonna three herbal medicines have the effect of antacid, hemostasis, detumescence, repairing ulcer, are adjuvant drug; The Radix Et Rhizoma Rhei (being commonly called as Radix Et Rhizoma Rhei), the Rhizoma Alpiniae Officinarum that add can be cleansed gastrointestinal excess-heat, relieving constipation cold expelling, preventing or arresting vomiting, are messenger drug.Wherein, Pseudobulbus Bletillae (Rhizoma Bletillae) astringing to arrest bleeding, detumescence and promoting granulation; But Os Sepiae antacid, hemostasis; Radix Et Rhizoma Rhei purging heat to relax the bowels, blood circulation promoting and blood stasis dispelling, to cleanse the intestines and stomach excess-heat stagnant; Rhizoma Alpiniae Officinarum can loose cold, the treatment epigastric pain of taste, preventing or arresting vomiting; Semen daturae Belladonna has auxiliary analgesic effect, and the Semen daturae in the pharmaceutical composition of the present invention is the commercial goods Semen daturae tablet, and every contains Semen daturae extractum 10mg, and weight proportion is in the Semen daturae extractum content in the Semen daturae tablet.
The present invention treats the pharmaceutical composition of gastropathy, is the medicament that is prepared from by the following weight proportion raw material:
0.5~1 part of WUJINGEN, 5~10 parts of wooly datchmanspipe roots, 3~5 parts of Rhizoma Corydalis, 20~50 parts of Herba Taraxacis, 0.6~1 part of Cortex Cinnamomi, 0.6~0.8 part of roud cardamon seed, 2.5~10 parts of Herba Pogostemonis, 2.5~6 parts of Fructus Aurantii Immaturuss, 2.5~5 parts of Cortex Magnoliae Officinalis, 0.8~5 part in Lignum Santali Albi, 0.3~0.8 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.1~2 part of Os Sepiae, 0.2~1 part of Radix Et Rhizoma Rhei, 2.5~5 parts of Rhizoma Alpiniae Officinarums, 0.01~0.015 part of Semen daturae Belladonna.
Further, it is the medicament that is prepared from by the following weight proportion raw material:
0.5 part of WUJINGEN, 5 parts of wooly datchmanspipe roots, 3 parts of Rhizoma Corydalis, 20 parts of Herba Taraxacis, 0.6 part of Cortex Cinnamomi, 0.6 part of roud cardamon seed, 2.5 parts of Herba Pogostemonis, 2.5 parts of Fructus Aurantii Immaturuss, 2.5 parts of Cortex Magnoliae Officinalis, 0.8 part in Lignum Santali Albi, 0.3 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.3 part of Os Sepiae, 0.2 part of Radix Et Rhizoma Rhei, 2.5 parts of Rhizoma Alpiniae Officinarums, 0.015 part of Semen daturae Belladonna.
The pharmaceutical composition that the present invention treats gastropathy is that containing with WUJINGEN, wooly datchmanspipe root, Rhizoma Corydalis, roud cardamon seed, Herba Pogostemonis, Fructus Aurantii Immaturus, Cortex Magnoliae Officinalis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Os Sepiae, Herba Taraxaci, Radix Et Rhizoma Rhei, Cortex Cinnamomi, Rhizoma Alpiniae Officinarum, Lignum Santali Albi crude drug or extract is active component, adds the medicament that Semen daturae and acceptable accessories or complementary composition are prepared from.
Wherein, described medicament is regular dosage forms such as powder, granule, capsule, tablet, oral liquid or mixture.
The present invention also provides the method for this pharmaceutical composition, and it comprises the steps:
A, take by weighing raw material by weight ratio: 0.5~1 part of WUJINGEN, 5~10 parts of wooly datchmanspipe roots, 3~5 parts of Rhizoma Corydalis, 20~50 parts of Herba Taraxacis, 0.6~1 part of Cortex Cinnamomi, 0.6~0.8 part of roud cardamon seed, 2.5~10 parts of Herba Pogostemonis, 2.5~6 parts of Fructus Aurantii Immaturuss, 2.5~5 parts of Cortex Magnoliae Officinalis, 0.8~5 part in Lignum Santali Albi, 0.3~0.8 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.1~2 part of Os Sepiae, 0.2~1 part of Radix Et Rhizoma Rhei, 2.5~5 parts of Rhizoma Alpiniae Officinarums, 0.01~0.015 part of Semen daturae Belladonna;
B, get the described raw material pulverizing powdered of step a, powder size is coarse powder, middle powder, fine powder, fine powder, impalpable powder, makes powder, or powder is packed in the softgel shell, makes capsule; Or
C, can also get the described raw material WUJINGEN of step a, roud cardamon seed, Herba Pogostemonis, Cortex Cinnamomi, Lignum Santali Albi, Rhizoma Alpiniae Officinarum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Cortex Magnoliae Officinalis distillating extracting oil, preserve the water extract, medicinal residues are standby;
D, get wooly datchmanspipe root, Rhizoma Corydalis, Herba Taraxaci, Fructus Aurantii Immaturus, Os Sepiae, Radix Et Rhizoma Rhei, add and remain medicinal residues after carrying volatile oil, decoct with water, filter filtrate, add aromatics medicine gained water extract, concentrate, drying is mixed with Semen daturae;
E, get said mixture, add the medicament that step c gained volatile oil and acceptable accessories or complementary composition are prepared from.
The present invention also provides the purposes of this pharmaceutical composition in the medicine of preparation treatment gastropathy.
Wherein, described gastropathy is acute gastritis, chronic gastritis, superficial gastritis, flatulence pain, gastric ulcer, digestive tract hemorrhage, duodenal ulcer, gastroduodenal complex ulcer, and the gastremia that also has gastric mucosa abscission, gastric mucosa abscission to cause is hemorrhage, acute gastric dilatation, pyloric obstruction; Also comprise diseases such as constipation, melena.It mainly is the gastropathy disease that causes at cold syndrome of the stomach, gastric qi.
Ten five tastes material combination are used and are had vital energy regualting and blood circulation-promoting, pain relieving, hemostasis, preventing or arresting vomiting, antacid, cold expelling, antiinflammatory, heat clearing away, healing ulcer, relieving constipation, relieving distension, appetite promoting and the spleen strengthening in the prescription of the present invention.Remarkable to a gastropathy and a digestive system treatment for diseases effect.Therapeutic process instant effect (general disease played a role after the half an hour of taking medicine, and alleviated the sufferer symptom), short treating period, difficult recurrence.According to the Chinese medical theory method of treatment rule of treatment, can also on prescription raw material of the present invention basis, set out according to the clinical diagnosis actual needs, add, subtract, replace the medicine of the relevant indication of treatment, and do not break away from the medicine method of treatment rule of treatment of the present invention.
Obviously, according to foregoing of the present invention,,, can also make modification, replacement or the change of other various ways not breaking away under the above-mentioned basic fundamental thought of the present invention prerequisite according to the ordinary skill knowledge and the customary means of this area.
The specific embodiment of form is described in further detail foregoing of the present invention again by the following examples.But this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following example.All technology that realizes based on foregoing of the present invention all belong to scope of the present invention.
The specific embodiment
The preparation of embodiment 1 powder of the present invention
A, take by weighing raw material: WUJINGEN 5g, wooly datchmanspipe root 50g, Rhizoma Corydalis 30g, roud cardamon seed 6g, Herba Pogostemonis 25g, Fructus Aurantii Immaturus 25g, CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China 25g, Pseudobulbus Bletillae (Rhizoma Bletillae) 3g, Os Sepiae 3g, Herba Taraxaci 200g, Radix Et Rhizoma Rhei 2g, Cortex Cinnamomi 6g, Rhizoma Alpiniae Officinarum 25g, Lignum Santali Albi 8g, Semen daturae Belladonna 0.15g by weight ratio;
B, get the described raw material pulverizing powdered of step a, powder size is a fine powder, makes powder.
This powder is 10 taking doses.
The preparation of embodiment 2 powders of the present invention
A, take by weighing raw material: WUJINGEN 5g, wooly datchmanspipe root 50g, Rhizoma Corydalis 30g, Herba Taraxaci 200g, Cortex Cinnamomi 6g by weight ratio;
B, get the described raw material pulverizing powdered of step a, powder size is an impalpable powder, makes powder.
This powder is 10 taking doses.
The preparation of embodiment 3 powders of the present invention
A, by weight ratio take by weighing raw material: WUJINGEN 5g, wooly datchmanspipe root 50g, Rhizoma Corydalis 30g, Herba Taraxaci 200g, Cortex Cinnamomi 6g, roud cardamon seed 6g, Herba Pogostemonis 25g, Fructus Aurantii Immaturus 25g, Cortex Magnoliae Officinalis 25g, Lignum Santali Albi 8g,
B, get the described raw material pulverizing powdered of step a, powder size is a fine powder, makes powder.
This powder is 10 taking doses.
The preparation of embodiment 4 powders of the present invention
A, take by weighing raw material: WUJINGEN 1g, wooly datchmanspipe root 10g, Rhizoma Corydalis 5g, roud cardamon seed 0.8g, Herba Pogostemonis 10g, Fructus Aurantii Immaturus 6g, CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China 5g, Pseudobulbus Bletillae (Rhizoma Bletillae) 0.8g, Os Sepiae 2g, Herba Taraxaci 50g, Radix Et Rhizoma Rhei 1g, Cortex Cinnamomi 1g, Rhizoma Alpiniae Officinarum 5g, Lignum Santali Albi 5g, Semen daturae Belladonna 0.015g by weight ratio;
B, get the described raw material pulverizing powdered of step a, powder size is made powder for fine powder.
This powder is 1 taking dose.
The preparation of embodiment 5 powders of the present invention
A, take by weighing raw material: WUJINGEN 15g, wooly datchmanspipe root 75g, Rhizoma Corydalis 50g, roud cardamon seed 65g, Herba Pogostemonis 75g, Fructus Aurantii Immaturus 60g, CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China 40g, Pseudobulbus Bletillae (Rhizoma Bletillae) 55g, Os Sepiae 15g, Herba Taraxaci 80g, Radix Et Rhizoma Rhei 10g, Cortex Cinnamomi 10g, Rhizoma Alpiniae Officinarum 40g, Lignum Santali Albi 40g, Semen daturae Belladonna 0.30g by weight ratio;
B, get the described raw material pulverizing powdered of step a, powder size is a coarse powder, makes powder.
This powder is 30 taking doses.
The preparation of embodiment 6 powders of the present invention
A, take by weighing raw material: WUJINGEN 1g, wooly datchmanspipe root 5g, Rhizoma Corydalis 5g, roud cardamon seed 0.8g, Herba Pogostemonis 10g, Fructus Aurantii Immaturus 5g, CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China 4g, Pseudobulbus Bletillae (Rhizoma Bletillae) 0.6g, Os Sepiae 2g, Herba Taraxaci 20g, Radix Et Rhizoma Rhei 0.8g, Cortex Cinnamomi 0.8g, Rhizoma Alpiniae Officinarum 4g, Lignum Santali Albi 3g, Semen daturae Belladonna0.015g by weight ratio;
B, get the described raw material pulverizing powdered of step a, powder size is an impalpable powder, makes powder.
This powder is 1 taking dose.
The preparation of embodiment 7 capsules of the present invention
Get embodiment 1,2,3,4,6 gained powders respectively and pack in the softgel shell, make capsule.The taking dose number of times is consistent with former embodiment.
The preparation of embodiment 8 pills of the present invention
Get the powder of embodiment 1~6 gained respectively, call in refined honey, be prepared into pill.The taking dose number of times is consistent with former embodiment.
The preparation of embodiment 9 tablets of the present invention
A, take by weighing raw material: WUJINGEN 50g, wooly datchmanspipe root 500g, Rhizoma Corydalis 300g, roud cardamon seed 60g, Herba Pogostemonis 250g, Fructus Aurantii Immaturus 200g, CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China 250g, Pseudobulbus Bletillae (Rhizoma Bletillae) 30g, Os Sepiae 30g, Herba Taraxaci 2000g, Radix Et Rhizoma Rhei 20g, Cortex Cinnamomi 60g, Rhizoma Alpiniae Officinarum 250g, Lignum Santali Albi 80g, Semen daturae Belladonna 1.5g by weight ratio;
B, get raw material WUJINGEN, roud cardamon seed, Herba Pogostemonis, Cortex Cinnamomi, Lignum Santali Albi, Rhizoma Alpiniae Officinarum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Cortex Magnoliae Officinalis described in the step a and carry volatile oil, preserve the water extract, medicinal residues are standby;
C, get step b surplus stock (remove Semen daturae), add and remain medicinal residues after carrying volatile oil, decoct with water, filter filtrate, add step c gained water extract, concentrate, drying is mixed with Semen daturae;
D, get step c mixture, add starch slurry and make soft material, granulate, granulate adds an amount of Pulvis Talci and magnesium stearate mix homogeneously, and tabletting promptly.
This tablet is 100 taking doses.
The preparation of embodiment 10 capsules of the present invention
A, take by weighing raw material: WUJINGEN 50g, wooly datchmanspipe root 500g, Rhizoma Corydalis 300g, roud cardamon seed 60g, Herba Pogostemonis 250g, Fructus Aurantii Immaturus 250g, CORTEX MAGNOLIAE OFFICINALIS from Sichuan of China 250g, Pseudobulbus Bletillae (Rhizoma Bletillae) 30g, Os Sepiae 30g, Herba Taraxaci 2000g, Radix Et Rhizoma Rhei 20g, Cortex Cinnamomi 60g, Rhizoma Alpiniae Officinarum 250g, Lignum Santali Albi 80g, Semen daturae Belladonna 1.5g by weight ratio;
B, get raw material WUJINGEN, roud cardamon seed, Herba Pogostemonis, Cortex Cinnamomi, Lignum Santali Albi, Rhizoma Alpiniae Officinarum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Cortex Magnoliae Officinalis described in the step a and carry volatile oil, preserve the water extract, medicinal residues are standby;
C, get step b surplus stock (remove Semen daturae), add and remain medicinal residues after carrying volatile oil, decoct with water, filter filtrate, add step c gained water extract, concentrate, drying is mixed with Semen daturae, pulverizing is encapsulated.
This capsule is 100 taking doses.
Below prove the beneficial effect of medicine of the present invention by case statistics and individual case.
Added up for 1 1998-2006 service time of clinical drug of the present invention, treat about 600 examples of total case, the patient suffers from stomach discomfort such as flatulence pain, gastritis, and diseases such as stomach, duodenal ulcer, according to the clinical case statistics of placing on record, therapeutic effect sees Table 1:
Use medicine during this time, with prescription 1 (WUJINGEN 0.5~1g, wooly datchmanspipe root 5~10g, Rhizoma Corydalis 3~5g, Herba Taraxaci 20~50g, Cortex Cinnamomi 0.6~1g, roud cardamon seed 0.6~0.8g, Herba Pogostemonis 2.5~10g, Fructus Aurantii Immaturus 2.5~6g, Cortex Magnoliae Officinalis 2.5~5g, Lignum Santali Albi 0.8~5g, the Pseudobulbus Bletillae (Rhizoma Bletillae) 0.3~0.8g, Os Sepiae 0.1~2g, Radix Et Rhizoma Rhei 0.2~1g, Rhizoma Alpiniae Officinarum 2.5~5g, Semen daturae Belladonna 0.01~0.015g, this dosage is a dose) be the basis, add according to clinical needs and to simplify the sanction prescription; Wherein preferred prescription 2 (WUJINGEN 0.5g, wooly datchmanspipe root 5g, Rhizoma Corydalis 3g, Herba Taraxaci 20g, Cortex Cinnamomi 0.6g, roud cardamon seed 0.6g, Herba Pogostemonis 2.5g, Fructus Aurantii Immaturus 2.5g, Cortex Magnoliae Officinalis 2.5g, Lignum Santali Albi 0.8g, Pseudobulbus Bletillae (Rhizoma Bletillae) 0.3g, Os Sepiae 0.3g, Radix Et Rhizoma Rhei 0.2g, Rhizoma Alpiniae Officinarum 2.5g, Semen daturae Belladonna 0.015g, this dosage are a dose) is made powder or capsule.
The concrete disease statistics of table 1 the present invention
Efficient calculating is to comprise that (recovery from illness refers to rehabilitation to two kinds of situations of recovery from illness and improvement, the disease complete obiteration in the above table; Improvement refer to disease alleviate, but not complete obiteration).Show curable substance various stomach symptom of the present invention, and therapeutic effect is remarkable, effective percentage mostly is 100%.
Add up 2 clinical drug typical case records of the present invention
1,31 years old flatulence pain of patient Li Gang man, melena, in February, 2003 certain hospital control seek medical advice fail to respond to any medical treatment after, take medicine of the present invention (embodiment 10 preparations) in June, 2003, day clothes 3 times treats after three months, recurrence was not seen in state of an illness elimination in 2 years.
2, the old dish woman of a specified duration of patient flatulence, belch occur 72 years old in March, 2004, takes medicine of the present invention (embodiment 10 preparations), and day clothes 3 times were treated after 7 days, and the state of an illness is eliminated and do not seen recurrence half a year.
3, patient Wang Qinan 58 years old flatulence pain, melena sought medical advice in August, 2002, takes medicine of the present invention (embodiment 10 preparations), and day clothes 3 times were treated after six months, and the state of an illness is eliminated and do not seen recurrence in 3 years.
4, patient Peng Binnan flatulence 25 years old in January, 2005, through medicine of the present invention (embodiment 1 preparation) treatment, day clothes 3 times were treated 2 days, and the state of an illness is eliminated and was not seen recurrence in five months.
5, patient's literary composition holt woman seeks medical advice 22 years old in March, 2005, disease performance flatulence pain, and through medicine of the present invention (embodiment 1 preparation) treatment, day clothes 3 times were treated 7 days, and the state of an illness is eliminated and is not seen recurrence.
According to inventor's clinical experience, in the regular dosage form of pharmaceutical composition of the present invention, curative effect is clear and definite, and the various disease conditions in the treatment gastropathy is all imitated soon, short treating period, and good effect is difficult for recurrence.Best in the dosage form with the capsule effect, for clinical treatment gastropathy provides a kind of new selection.
Claims (7)
1, a kind of pharmaceutical composition for the treatment of gastropathy is characterized in that: it is the medicament that is prepared from by following raw materials by weight proportions:
0.5~1 part of WUJINGEN, 5~10 parts of wooly datchmanspipe roots, 3~5 parts of Rhizoma Corydalis, 20~50 parts of Herba Taraxacis, 0.6~1 part of Cortex Cinnamomi, 0.6~0.8 part of roud cardamon seed, 2.5~10 parts of Herba Pogostemonis, 2.5~6 parts of Fructus Aurantii Immaturuss, 2.5~5 parts of Cortex Magnoliae Officinalis, 0.8~5 part in Lignum Santali Albi, 0.3~0.8 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.1~2 part of Os Sepiae, 0.2~1 part of Radix Et Rhizoma Rhei, 2.5~5 parts of Rhizoma Alpiniae Officinarums, 0.01~0.015 part of Semen daturae.
2, the pharmaceutical composition of treatment gastropathy according to claim 1 is characterized in that: it is the medicament that is prepared from by following raw materials by weight proportions:
0.5 part of WUJINGEN, 5 parts of wooly datchmanspipe roots, 3 parts of Rhizoma Corydalis, 20 parts of Herba Taraxacis, 0.6 part of Cortex Cinnamomi, 0.6 part of roud cardamon seed, 2.5 parts of Herba Pogostemonis, 2.5 parts of Fructus Aurantii Immaturuss, 2.5 parts of Cortex Magnoliae Officinalis, 0.8 part in Lignum Santali Albi, 0.3 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.3 part of Os Sepiae, 0.2 part of Radix Et Rhizoma Rhei, 2.5 parts of Rhizoma Alpiniae Officinarums, 0.015 part of Semen daturae.
3, the pharmaceutical composition of treatment gastropathy according to claim 1 and 2, it is characterized in that: it is that containing with WUJINGEN, wooly datchmanspipe root, Rhizoma Corydalis, roud cardamon seed, Herba Pogostemonis, Fructus Aurantii Immaturus, Cortex Magnoliae Officinalis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Os Sepiae, Herba Taraxaci, Radix Et Rhizoma Rhei, Cortex Cinnamomi, Rhizoma Alpiniae Officinarum, Lignum Santali Albi crude drug is active component, adds the medicament that Semen daturae and acceptable accessories are prepared from.
4, the pharmaceutical composition of treatment gastropathy according to claim 3 is characterized in that: described medicament is powder, granule, capsule, tablet, oral liquid or mixture.
5, a kind of method for preparing the pharmaceutical composition of each described treatment gastropathy of claim 1~4, it comprises the steps:
A, weighting raw materials by weight ratio: 0.5~1 part of WUJINGEN, 5~10 parts of wooly datchmanspipe roots, 3~5 parts of Rhizoma Corydalis, 20~50 parts of Herba Taraxacis, 0.6~1 part of Cortex Cinnamomi, 0.6~0.8 part of roud cardamon seed, 2.5~10 parts of Herba Pogostemonis, 2.5~6 parts of Fructus Aurantii Immaturuss, 2.5~5 parts of Cortex Magnoliae Officinalis, 0.8~5 part in Lignum Santali Albi, 0.3~0.8 part of the Pseudobulbus Bletillae (Rhizoma Bletillae), 0.1~2 part of Os Sepiae, 0.2~1 part of Radix Et Rhizoma Rhei, 2.5~5 parts of Rhizoma Alpiniae Officinarums, 0.01~0.015 part of Semen daturae;
B, get the described raw material pulverizing powdered of step a, powder size is coarse powder, middle powder, fine powder, fine powder or impalpable powder, makes powder, or powder is packed in the softgel shell, makes capsule; Or
C, get raw material WUJINGEN described in the step a, roud cardamon seed, Herba Pogostemonis, Cortex Cinnamomi, Lignum Santali Albi, Rhizoma Alpiniae Officinarum, the Pseudobulbus Bletillae (Rhizoma Bletillae), Cortex Magnoliae Officinalis distillating extracting oil, preserve the water extract, medicinal residues are standby;
D, get wooly datchmanspipe root, Rhizoma Corydalis, Herba Taraxaci, Fructus Aurantii Immaturus, Os Sepiae, Radix Et Rhizoma Rhei, add and remain medicinal residues after step c carries volatile oil, decoct with water, filter filtrate, add step c gained water extract, concentrate, drying is mixed with Semen daturae;
E, get the steps d mixture, add the preparation of step c gained volatile oil and acceptable accessories and get final product.
6, the purposes of the described pharmaceutical composition of claim 1 in the medicine of preparation treatment gastropathy.
7, purposes according to claim 6 is characterized in that: described gastropathy is cold syndrome of the stomach, gastric qi, flatulence pain, gastritis, digestive tract hemorrhage, gastric ulcer, duodenal ulcer or constipation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100213944A CN100471519C (en) | 2006-07-14 | 2006-07-14 | Medicine composition for treating stomach diseases and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100213944A CN100471519C (en) | 2006-07-14 | 2006-07-14 | Medicine composition for treating stomach diseases and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1899558A CN1899558A (en) | 2007-01-24 |
CN100471519C true CN100471519C (en) | 2009-03-25 |
Family
ID=37655669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100213944A Expired - Fee Related CN100471519C (en) | 2006-07-14 | 2006-07-14 | Medicine composition for treating stomach diseases and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100471519C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102688433B (en) * | 2012-06-14 | 2013-10-09 | 李良 | Galangal Chinese medicinal decoction for treating stomachache and preparation method thereof |
CN102940855B (en) * | 2012-12-07 | 2014-04-16 | 青岛市市立医院 | Pharmaceutical composition for treating gastropathy and preparation method of pharmaceutically composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301560A (en) * | 1999-12-29 | 2001-07-04 | 苗少伯 | Method for preparing medicine for curing gastropathy |
CN1418693A (en) * | 2002-12-11 | 2003-05-21 | 李哲 | Oral liquid medicine for treating stomach-pain, and its prepn. method |
CN1431010A (en) * | 2003-01-20 | 2003-07-23 | 叶彬 | Medicine for treating discomforts in insteines and stomach |
-
2006
- 2006-07-14 CN CNB2006100213944A patent/CN100471519C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301560A (en) * | 1999-12-29 | 2001-07-04 | 苗少伯 | Method for preparing medicine for curing gastropathy |
CN1418693A (en) * | 2002-12-11 | 2003-05-21 | 李哲 | Oral liquid medicine for treating stomach-pain, and its prepn. method |
CN1431010A (en) * | 2003-01-20 | 2003-07-23 | 叶彬 | Medicine for treating discomforts in insteines and stomach |
Non-Patent Citations (4)
Title |
---|
中西医结合治疗慢性胃炎的临床报告. 汪玲等.蚌埠医药,第13卷第3期. 1995 |
中西医结合治疗慢性胃炎的临床报告. 汪玲等.蚌埠医药,第13卷第3期. 1995 * |
陆拯从脏间关系论治脾胃病四法. 张烨敏.江苏中医,第21卷第1期. 2000 |
陆拯从脏间关系论治脾胃病四法. 张烨敏.江苏中医,第21卷第1期. 2000 * |
Also Published As
Publication number | Publication date |
---|---|
CN1899558A (en) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101019975A (en) | Fracture treating Chinese medicine composition and its prepn | |
CN100384463C (en) | Medicine for trenting flooding and spotting, haematemesis and homafecia | |
CN101474269A (en) | Application of pharmaceutical composition in preparing medicament for preventing and treating gynecology disease | |
CN101757591B (en) | Traditional Chinese medicine composition for treating chronic colitis and protitis | |
CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
CN100471519C (en) | Medicine composition for treating stomach diseases and preparation method and application thereof | |
CN101342282B (en) | Chinese medicinal composition for treating gastropathy and preparation method | |
CN101983695A (en) | Traditional Chinese medicine composition for curing hemiplegia and preparation method thereof | |
CN101513491A (en) | Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN101317958B (en) | Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof | |
CN100488526C (en) | Oral preparation | |
CN104998019B (en) | A kind of promoting blood circulation and removing blood stasis, Chinese medicine composition of hemostasis and pain-relieving | |
CN101695534B (en) | Chinese patent medicament for treating mammary gland disease | |
CN102641413A (en) | Medicine for treating acute enteritis and preparing method thereof | |
CN101224251B (en) | Chinese prepared medicine for treating chronic gastritis | |
CN102813875B (en) | Traditional Chinese medicine composition for treating lupus erythematosus as well as application thereof | |
CN106668787A (en) | Traditional Chinese medicine honeyed pill for treating hepatonecrosis and liver cancer and preparation method of traditional Chinese medicine honeyed pill | |
CN106860646B (en) | Traditional Chinese medicine composition for treating gastroduodenal ulcer and preparation method thereof | |
CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
CN106853193A (en) | It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof | |
CN104922397B (en) | A kind of promoting blood circulation and removing blood stasis, application of the Chinese medicine composition of hemostasis and pain-relieving | |
CN103893733A (en) | Preparation method of traditional Tibetan medicine for treating chronic gastritis | |
CN114209738A (en) | Traditional Chinese medicine composition and traditional Chinese medicine liquor for clearing heat, dispelling wind and dredging collaterals and preparation method thereof | |
CN103432502A (en) | Traditional Chinese patent medicine for treating peptic ulcer disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090325 Termination date: 20110714 |